Liabilities of NYMOX PHARMACEUTICAL CORP from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
NYMOX PHARMACEUTICAL CORP quarterly Liabilities in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • NYMOX PHARMACEUTICAL CORP Liabilities for the quarter ending 31 Dec 2024 was $7,429,000, a 96% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

NYMOX PHARMACEUTICAL CORP Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $7,429,000 +$3,629,000 +96% 31 Dec 2024 20-F 03 Jun 2025 2024 FY
Q3 2024 $6,920,000 +$4,349,000 +169% 30 Sep 2024 6-K 02 Jan 2025 2024 Q3
Q4 2023 $3,800,000 +$1,693,000 +80% 31 Dec 2023 20-F 03 Jun 2025 2024 FY
Q3 2023 $2,571,000 +$203,000 +8.6% 30 Sep 2023 6-K 15 Nov 2023 2023 Q3
Q2 2023 $3,148,000 +$906,000 +40% 30 Jun 2023 6-K 14 Aug 2023 2023 Q2
Q1 2023 $2,374,000 -$254,000 -9.7% 31 Mar 2023 6-K 12 May 2023 2023 Q1
Q4 2022 $2,107,000 +$158,000 +8.1% 31 Dec 2022 20-F 29 Aug 2024 2023 FY
Q3 2022 $2,368,000 +$100,000 +4.4% 30 Sep 2022 6-K/A 16 Nov 2022 2022 Q3
Q2 2022 $2,242,000 +$279,000 +14% 30 Jun 2022 6-K 15 Aug 2022 2022 Q2
Q1 2022 $2,628,000 +$1,161,000 +79% 31 Mar 2022 6-K 13 May 2022 2022 Q1
Q4 2021 $1,949,000 -$249,000 -11% 31 Dec 2021 20-F 02 May 2023 2022 FY
Q3 2021 $2,268,000 +$372,000 +20% 30 Sep 2021 6-K 12 Nov 2021 2021 Q3
Q2 2021 $1,963,000 -$156,000 -7.4% 30 Jun 2021 6-K 13 Aug 2021 2021 Q2
Q1 2021 $1,467,000 -$463,000 -24% 31 Mar 2021 6-K 14 May 2021 2021 Q1
Q4 2020 $2,198,000 +$157,000 +7.7% 31 Dec 2020 20-F 30 Mar 2022 2021 FY
Q3 2020 $1,896,000 +$84,000 +4.6% 30 Sep 2020 6-K 13 Nov 2020 2020 Q3
Q2 2020 $2,119,000 +$169,000 +8.7% 30 Jun 2020 6-K 14 Aug 2020
Q1 2020 $1,930,000 +$219,000 +13% 31 Mar 2020 6-K 14 May 2020 2020 Q1
Q4 2019 $2,041,000 +$967,000 +90% 31 Dec 2019 20-F 30 Mar 2022 2021 FY
Q3 2019 $1,812,000 +$963,000 +113% 30 Sep 2019 6-K 13 Nov 2019 2019 Q3
Q2 2019 $1,950,000 +$335,000 +21% 30 Jun 2019 6-K 14 Aug 2019 2019 Q2
Q1 2019 $1,711,000 -$287,000 -14% 31 Mar 2019 6-K 15 May 2019 2019 Q1
Q4 2018 $1,074,000 -$1,156,000 -52% 31 Dec 2018 20-F 29 Mar 2021 2020 FY
Q3 2018 $849,000 30 Sep 2018 6-K 13 Nov 2018 2018 Q3
Q2 2018 $1,615,000 30 Jun 2018 6-K 13 Aug 2018 2018 Q2
Q1 2018 $1,998,000 31 Mar 2018 6-K 15 May 2018 2018 Q1
Q4 2017 $2,230,000 -$69,000 -3% 31 Dec 2017 20-F 30 Mar 2020 2019 FY
Q4 2016 $2,299,000 -$761,000 -25% 31 Dec 2016 20-F 29 Mar 2019 2018 FY
Q4 2015 $3,060,000 31 Dec 2015 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.